Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after hepatitis C virus eradication.
chronic hepatitis C
direct-acting antiviral
enhanced liver fibrosis score
hepatocellular carcinoma
sustained virological response
Journal
Molecular and clinical oncology
ISSN: 2049-9469
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
17
01
2021
accepted:
07
07
2021
entrez:
3
9
2021
pubmed:
4
9
2021
medline:
4
9
2021
Statut:
ppublish
Résumé
Advanced liver fibrosis is the most important risk factor for hepatocellular carcinoma (HCC) development after achieving sustained virological response (SVR) by direct-acting antiviral (DAA) treatment in patients with chronic hepatitis C.
Identifiants
pubmed: 34476099
doi: 10.3892/mco.2021.2377
pii: MCO-0-0-02377
pmc: PMC8408682
doi:
Types de publication
Journal Article
Langues
eng
Pagination
215Informations de copyright
Copyright: © Kawaguchi et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Ann Intern Med. 2000 Apr 4;132(7):517-24
pubmed: 10744587
Scand J Gastroenterol. 1994 May;29(5):474-9
pubmed: 7518613
Hepatology. 2013 Jan;57(1):103-11
pubmed: 22930399
Hepatology. 2013 Oct;58(4):1253-62
pubmed: 23564522
J Hepatol. 2017 Sep 5;:
pubmed: 28887168
Gastroenterology. 2017 Oct;153(4):996-1005.e1
pubmed: 28642197
J Viral Hepat. 2011 Jan;18(1):23-31
pubmed: 20196799
Hepatol Res. 2016 Jul;46(8):758-64
pubmed: 26574180
Hepatology. 2008 Feb;47(2):455-60
pubmed: 18038452
J Viral Hepat. 2021 Jan;28(1):129-141
pubmed: 32869924
PLoS One. 2014 Oct 28;9(10):e111551
pubmed: 25350286
Am J Gastroenterol. 2004 Feb;99(2):271-9
pubmed: 15046217
Clin Chem. 2018 Sep;64(9):1404-1405
pubmed: 29941470
BMJ Open Gastroenterol. 2018 Jun 29;5(1):e000207
pubmed: 30002863
Clin Exp Med. 2018 Feb;18(1):45-50
pubmed: 28567544
PLoS One. 2018 Mar 13;13(3):e0194163
pubmed: 29534101
Hepatology. 2018 Jun;67(6):2244-2253
pubmed: 29205416
Hepatology. 2008 Nov;48(5):1549-57
pubmed: 18846542
Aliment Pharmacol Ther. 2018 Mar;47(5):550-562
pubmed: 29327780
Hepatol Res. 2018 Dec;48(13):1131-1139
pubmed: 30030872
Eur J Gastroenterol Hepatol. 2019 Jan;31(1):43-46
pubmed: 30134384
Hepatology. 2007 Jul;46(1):32-6
pubmed: 17567829
Gastroenterology. 2018 Aug;155(2):411-421.e4
pubmed: 29655836
Gastroenterology. 2004 Dec;127(6):1704-13
pubmed: 15578508
J Clin Med. 2018 Sep 11;7(9):
pubmed: 30208564
Clin Chim Acta. 2002 Feb;316(1-2):71-81
pubmed: 11750276
J Hepatol. 2017 Nov;67(5):933-939
pubmed: 28627363
Hepatology. 2014 Nov;60(5):1563-70
pubmed: 25042054
PLoS One. 2018 Apr 4;13(4):e0195632
pubmed: 29617443
Gastroenterology. 2019 Nov;157(5):1264-1278.e4
pubmed: 31356807
Hepatol Res. 2013 Dec;43(12):1327-42
pubmed: 23458062
Med Sci Monit. 2019 Sep 27;25:7243-7250
pubmed: 31558693
Dig Liver Dis. 2016 Mar;48(3):291-7
pubmed: 26514736
BMC Gastroenterol. 2019 Apr 27;19(1):63
pubmed: 31029101
J Gastroenterol Hepatol. 2000 Aug;15(8):945-51
pubmed: 11022838
Hepatol Res. 2015 Jan;45(2):152-61
pubmed: 25052449
Liver Int. 2017 Mar;37(3):369-376
pubmed: 27678216